Hallucinogens Flashcards
(15 cards)
1
Q
altered state of consciousness
A
classical - plant derived substances, synthetic drugs
dissociative - anaesthesia, altered state consciousness, NMDA receptor antagonists
2
Q
5 dimensions
A
- oceanic boundlessness
- anxious ego - disintegration
- visionary
- restructuralisation
- acoustic alterations
3
Q
subjective experience
A
- less predictable
- dependent on expectation and the environment
- cannot be predicted - Groff
4
Q
serotonergic neurons
A
- meta analysis of neuroimaging
- SERT changes - decreased in NMDA users
- ppts heavy users
5
Q
treatment of neuropsychiatric disorders
A
- psychotherapy to facilitate experience
- depression and alcohol dependence
- potential for bad trips
- MDMA toxicity for serotonergic neurons
6
Q
ketamine treatment for resistant depression
A
- duration is variable
- not all patients respond
- potential adverse effects
- nasal spray but not approved for NHS funding
7
Q
historical background
A
- used as part of rituals
- entered main stream in 20th century
- ketamine is a safer alternative
- clinically exploited in Europe and North America
- 1960s - associated with counter culture
- ketamine as antidepressant in 2019
8
Q
ecstasy
A
- MDMA effects serotonin transmission
- stimulant properties
- use in psychotherapy
- 0.4% 16-59 year olds take LSD
9
Q
harmfulness
A
- virtually no physical harm or dependence
- ecstasy does > degeneration
- 130 ecstasy related deaths
10
Q
legal restrictions
A
- 3 classes to determine penalties
- 5 schedules regulate clinical use of controlled substances
11
Q
classical hallucinogens
A
activate serotonin and 5HT2A receptor activation is main contributor to psychological effects
primary neuropharmacological mechanism is stimulation of 5HT receptors
12
Q
serotonin system and 5HT2A
A
- serotonergic raphe nuclei in midbrain
- 5HT2A are G protein - coupled stimulatory effects on neurons
- stimulate excitatory neurons, crucial for hallucinogenic effects
13
Q
MDMA
A
- stimulates serotonin release and dopamine releas
14
Q
dissociative anaesthetics
A
- primary neuropharmacological blockade of channel pore
- increase neural excitation
- stimulate PFC and NA dopamine release
15
Q
adverse effects
A
- dependence
- neurodegeneration
- ketamine bladder